SAPONARO, CONCETTA
SAPONARO, CONCETTA
Alteration of Na/H exchange regulatory factor-1 protein levels in anogenital lesions positive for mucosal high-risk human papillomavirus type 16
2022-01-01 Saponaro, C; Galati, L; Gheit, T; Pappagallo, Sa; Zambetti, M; Zito, Fa; Cardone, Ra; Reshkin, Sj; Tommasino, M
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy
2022-01-01 Porcelli, Letizia; Di Fonte, Roberta; Pierri, Ciro L; Fucci, Livia; Saponaro, Concetta; Armenio, Andrea; Serratì, Simona; Strippoli, Sabino; Fasano, Rossella; Volpicella, Mariateresa; Daprile, Rossana; Tommasi, Stefania; Ressa, Cosmo M; Guida, Michele; Azzariti, Amalia
High density of tryptase-positive mast cells in human colorectal cancer: A poor prognostic factor related to protease-activated receptor 2 expression
2013-01-01 Malfettone, A.; Silvestris, N.; Saponaro, C.; Ranieri, G.; Russo, A.; Caruso, S.; Popescu, O.; Simone, G.; Paradiso, A.; Mangia, A.
NHERF1 and tumor microenvironment: A new scene in invasive breast carcinoma
2018-01-01 Saponaro, C.; Vagheggini, A.; Scarpi, E.; Centonze, M.; Catacchio, I.; Popescu, O.; Pastena, M. I.; Giotta, F.; Silvestris, N.; Mangia, A.
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
2020-01-01 Sonnessa, M.; Cioffi, A.; Brunetti, O.; Silvestris, N.; Zito, F. A.; Saponaro, C.; Mangia, A.
Should tumor infiltrating lymphocytes, androgen receptor, and FOXA1 expression predict the clinical outcome in triple negative breast cancer patients?
2019-01-01 Mangia, A.; Saponaro, Concetta; Vagheggini, A.; Opinto, G.; Centonze, M.; Vicenti, C.; Popescu, O.; Pastena, M.; Giotta, F.; Silvestris, N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Alteration of Na/H exchange regulatory factor-1 protein levels in anogenital lesions positive for mucosal high-risk human papillomavirus type 16 | 1-gen-2022 | Saponaro, C; Galati, L; Gheit, T; Pappagallo, Sa; Zambetti, M; Zito, Fa; Cardone, Ra; Reshkin, Sj; Tommasino, M | |
| BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy | 1-gen-2022 | Porcelli, Letizia; Di Fonte, Roberta; Pierri, Ciro L; Fucci, Livia; Saponaro, Concetta; Armenio, Andrea; Serratì, Simona; Strippoli, Sabino; Fasano, Rossella; Volpicella, Mariateresa; Daprile, Rossana; Tommasi, Stefania; Ressa, Cosmo M; Guida, Michele; Azzariti, Amalia | |
| High density of tryptase-positive mast cells in human colorectal cancer: A poor prognostic factor related to protease-activated receptor 2 expression | 1-gen-2013 | Malfettone, A.; Silvestris, N.; Saponaro, C.; Ranieri, G.; Russo, A.; Caruso, S.; Popescu, O.; Simone, G.; Paradiso, A.; Mangia, A. | |
| NHERF1 and tumor microenvironment: A new scene in invasive breast carcinoma | 1-gen-2018 | Saponaro, C.; Vagheggini, A.; Scarpi, E.; Centonze, M.; Catacchio, I.; Popescu, O.; Pastena, M. I.; Giotta, F.; Silvestris, N.; Mangia, A. | |
| NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer | 1-gen-2020 | Sonnessa, M.; Cioffi, A.; Brunetti, O.; Silvestris, N.; Zito, F. A.; Saponaro, C.; Mangia, A. | |
| Should tumor infiltrating lymphocytes, androgen receptor, and FOXA1 expression predict the clinical outcome in triple negative breast cancer patients? | 1-gen-2019 | Mangia, A.; Saponaro, Concetta; Vagheggini, A.; Opinto, G.; Centonze, M.; Vicenti, C.; Popescu, O.; Pastena, M.; Giotta, F.; Silvestris, N. |